Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain

ClinicalTrials.gov ID: NCT00387010

Public ClinicalTrials.gov record NCT00387010. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4-week Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of the study is to evaluate the impact of treatment with fentanyl buccal tablets on the anxiety symptoms commonly associated with chronic pain in patients with breakthrough pain (BTP). Other purposes are to assess the management of BTP, to evaluate patient functioning, and to determine any influences on the successful dose achieved.

Study identification

NCT ID
NCT00387010
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
218 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2006 (Type not available)
Primary completion
Oct 2007 (Actual)
Completion
Oct 2007 (Actual)
Last update posted
Oct 22, 2012

2006 – 2007

United States locations

U.S. sites
33
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Birmingham Pain Center Birmingham Alabama 35244 —
Arizona Research Center Phoenix Arizona 85023 —
Orange County Clinical Trials Anaheim California 92801 —
Vertex Clinical Research Bakersfield California 93311 —
Lovelace Scientific Resources, Inc. Beverly Hills California 90211 —
Synergy Clinical Research Center National City California 91950 —
Pain Institute of Santa Monica Santa Monica California 90404 —
Integrative Pain Manage Centers Westminster Colorado 80021 —
Advanced Diagnostic Pain Treatment Center New Haven Connecticut 06511 —
Alliance Medical Research Group Clearwater Florida 33761 —
Innovative Research of West Florida Largo Florida 33770 —
Lovelace Scientific Resources, Inc. Sarasota Florida 34233 —
Stedman Clinical Trials Tampa Florida 33647 —
Dawsonville Family Medicine Dawsonville Georgia 30534 —
Millennium Pain Center Bloomington Illinois 61701 —
Pain and Rehabilitation Clinic of Chicago Chicago Illinois 60610 —
Elkhart Clinic, LLC Elkhart Indiana 46514 —
Rehabilitation Associates of Indiana Indianapolis Indiana 46250 —
Northwest Indiana Center for Clinical Research, PC Valparaiso Indiana 46383 —
ICRI, Inc. Overland Park Kansas 66211 —
Willis-Knighton Pain Management Center Shreveport Louisiana 71103 —
Montana Cancer Specialists Missoula Montana 59802 —
Lovelace Scientific Resources Center Henderson Nevada 89014 —
Clinical Research Center of Nevada Las Vegas Nevada 89104 —
SUNY - Stonybrook Stony Brook New York 11794 —
Pain Consultants of Oregon Eugene Oregon 97401 —
Allegheny Pain Management, PC Altoona Pennsylvania 16602 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
DeGarmo Institute of Medical Research Greer South Carolina 29651 —
Comprehensive Pain Specialists, PLLC Hendersonville Tennessee 37075 —
KRK Medical Research Richardson Texas 75080 —
BeXar Clinical Trials, LLC Richardson Texas 75082 —
Lifetree Clinical Research Salt Lake City Utah 84106 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00387010, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2012 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00387010 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →